Vertex Pharmaceuticals Incorporated (VRTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 115.92B |
| Enterprise Value | 114.72B |
| P/E Ratio | 31.87 |
| PEG Ratio | 1.42 |
| Price/Sales Ratio | 11.1 |
| Price/Book Ratio | 6.92 |
| Enterprise/Revenue | 10.77 |
| Enterprise/EBITDA | 24.97 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.35 |
| Operating Margin | 0.39 |
| Return On Assets | 0.16 |
| Return On Equity | 0.23 |
| Revenue | 12.07B |
| Revenue/Share | 49.72 |
| Gross Profit | 10.27B |
| EBITDA | 4.86B |
| Net Income | 3.95B |
| Diluted EPS | 15.32 |
| Total Cash | 7.85B |
| Total Cash/Share | 30.93 |
| Total Debt | 1.98B |
| Total Debt/Equity | 0.1 |
| Current Ratio | 3.19 |
| Book Value Per Share | 79.75 |
| 52-Week Change | 41.28 |
| 52-Week High | 553.69 |
| 52-Week Low | 374.17 |
| Moving Average 50 Days | 484.54 |
| Moving Average 200 Days | 458.13 |
| Average Volume | 1.57M |
| Shares Outstanding | 253.81M |
| % Held by Institutions | 95.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | August 24, 2000 |